Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xue Tian Yue"'
Autor:
Rui Cheng Wei, Yu Mei Wu, Xue Tian Yue, Xinyuan Liu, Kang Jian Zhang, Gongchu Li, Su Yang Zhong, Xin Cao, Yigang Wang
Publikováno v:
Human Gene Therapy. 20:818-830
Interleukin (IL)-24 is an excellent therapeutic gene for cancer therapy. In this work, IL-24 was inserted into Ad.sp-E1A(Delta24), an oncolytic adenovirus with a 24-bp deletion in the E1A gene, which was driven by the survivin promoter to form Ad.sp-
Autor:
Wei, Zhang, Xiao, Tong, Tadashi, Nakasone, Xue-Tian, Yue, Naoki, Yamamoto, Xin-Yuan, Liu, Rong-Ge, Yang
Publikováno v:
Chinese medical journal. 124(3)
Interferon (IFN) can inhibit human immunodeficiency virus type 1 (HIV-1) replication in vitro and in clinic. However, IFN therapy for HIV infection was limited by its moderate antiviral efficacy and its frequent adverse effects. In the present study
Autor:
Yigang Wang, Gongchu Li, Yi Yang, Na Li, Yi-qiang Wang, Yu-mei Wu, Kang-jian Zhang, Xue-tian Yue
Publikováno v:
Acta pharmacologica Sinica. 30(4)
The aim of this study was to creatively implement a novel chemo-gene-virotherapeutic strategy and further strengthen the antitumor effect in cancer cells by the combined use of ZD55-IL-24 and cisplatin. ZD55-IL-24 is an oncolytic adenovirus that harb
Autor:
Yu-mei WU, Kang-jian ZHANG, Xue-tian YUE, Yi-qiang WANG, Yi YANG, Gong-chu LI, Na LI, Yi-gang WANG
Publikováno v:
Acta Pharmacologica Sinica; Apr2009, Vol. 30 Issue 4, p467-477, 11p, 1 Color Photograph, 2 Black and White Photographs, 1 Diagram, 4 Graphs
Autor:
Kang Jian Zhang, Yi Gang Wang, Xin Cao, Su Yang Zhong, Rui Cheng Wei, Yu Mei Wu, Xue Tian Yue, Gong Chu Li, Xin Yuan Liu
Publikováno v:
Human Gene Therapy; Aug2009, Vol. 20 Issue 8, p818-830, 13p
Publikováno v:
Drug Week; 10/8/2024, p2155-2155, 1p